BioCentury
ARTICLE | Company News

American Biogenetic, Biosite Diagnostics Inc. deal

April 9, 2001 7:00 AM UTC

BSTE will evaluate the use of MABA's Thrombus Precursor Protein ( TpP) diagnostic marker and antibodies for use with BSTE's Triage Meter point-of-care testing platform. If BSTE decides to market prod...